Benzodiazepines and other sedative-hypnotics are not recommended as first-line treatment for insomnia, agitation, and delirium in older adults. Long-term use of these medications can be harmful, and increase the risks of falls, hip fractures, as well as lead to other adverse events.

Join the De/Implement series on April 27 at 12 p.m. ET to discuss a recently published study on using a quality improvement approach to decrease sedative-hypnotics across multiple hospital sites. Dr. Christine Soong, Medical Director of Quality and Safety at Sinai Health, will describe the intervention, share findings, and discuss how to sustain these efforts.

Missed the webinar? Watch it now.